Study of Epcoritamab in R/R Primary Diffuse Large B-cell Lymphoma of the CNS Treated With Lenalidomide and Rituximab

NCT06931652 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Primary CNS Lymphoma (PCNSL)

Interventions

DRUG: Epcoritamab

Sponsor

The Lymphoma Academic Research Organisation

Collaborators

[object Object]